About Us

ABOUT US

teams rewards

At genXone, we apply nanopore sequencing technology (third-generation of NGS) to many areas of science and business, including genetic diagnostics and the food industry. We are the first in Poland commercial certified partner of Oxford Nanopore Technologies (ONT), the world leader in biotechnology innovation (www.nanoporetech.com).

We specialise in developing new products and solutions based on the latest technologies of nucleic acid sequencing. Our team includes specialists in the field of microbiome research, polygenic diseases, RNA, genomics, metagenomics, bacteriophage transcriptomics, nutrigenomics, genetics of metabolic diseases, molecular ecology, genetic engineering and bioinformatics. The team is completed by specialists in administration, quality management and marketing.

Outside of work, we have a total of 21 wonderful children, 5 cats, 4 dogs and some hamsters. While sequencing technologies are our passion, after hours we also enjoy breakdance, boogie woogie, fitness, weightlifting, triathlons, judo, off-road tourism, hunting, fishing, photography, cycling, travel, nutrition, as well as cooking and eating healthy. Between ourselves, we have visited a total of 43 countries so far. Together, we form a dynamic team of ambitious experts.

OUR LEADERSHIP

Michał Kaszuba, PhD

dr Michał Kaszuba

As the CEO, initiator and co-founder of genXone, Michał is a true innovator and entrepreneur. A graduate of the University of Warmia and Mazury in Olsztyn, Faculty of Biology and the Institute of Genetics and Animal Breeding of the Polish Academy of Sciences (PhD in Agricultural Sciences). He has gained extensive experience in research and development projects in biology and genetics. He received a number of honours and awards for his scientific achievements. Among others: the Marshal of the Wielkopolska Region award in the Micro Future category (2007). Michał is also a two-time finalist of the well-known Ernst & Young Entrepreneur of the Year competition in the New Business category (2009 and 2010).   

Background:
2016: Initiator and co-founder of genXone
2010: President of the Management Board and co-owner of NewLab System
2010 – 2014: President of the Management Board of Inno-Gene, a company listed on the Polish stock exchange, contributed to a number development projects carried out within this period and helped implement innovative solutions in the field of genetics
2006 – 2014: Co-founder and member of the Management Board of DNA Research Center

Łukasz Krych, Associate professor

dr Łukasz Krych

Director of Research and Development at genXone. Łukasz completed his PhD at the University of Copenhagen in Denmark (2011 – 2014). Then he continued as a postdoctoral researcher at ETH Zurich, Switzerland (2016 – 2017). Since 2014, he has worked as a postdoctoral research fellow at the University of Copenhagen. Between 2008 and 2010, he was a research and development assistant at the DNA Research Center in Poznan. He published 58 articles in international academic journals (h-index: 18).

Łukasz Krych has a strong international academic background and expertise in a wide range of molecular techniques and the analysis of NGS data. His main  research interests include:

  • research in and understanding of the relationship between intestinal microbiome and health, and disease in human and animal models;
  • molecular genetic methods and classic microbiological methods for detection, identification and characterisation of complex microorganism groups;
  • detection of bacteria, yeast and phage associated with food processing and food pathogens; understanding of the effect of diet on microbiological composition in “in vivo” and “in vitro” models of mammalian gastrointestinal tract;
  • development and optimisation of protocols for NGS sequencing (Illumina, MiSeq, NextSeq, Oxford Nanopores) and high-throughput qPCR; research and development of modern molecular tests in diagnostics of genetic diseases and detection of pathogens;
  • analysis of NGS data including sequencing of amplicons, metagenomes and their annotation (Qiime, C ++, R, Matlab, bash);
  • hardware assembly and software management on custom-made computers;
  • construction of Unix-based computing sets, including servers, for advanced data analysis